Keyphrases
Adverse Effects
15%
Cardiac Death
7%
Cardiac Hospitalization
7%
Cardiac Retransplantation
7%
Cardiovascular Magnetic Resonance Imaging
100%
Composite Endpoint
15%
Coronary Allograft Vasculopathy
7%
Cumulative Incidence
7%
Heart Transplant Recipients
100%
Heart Transplantation
15%
High Incidence
7%
High Risk
7%
High-degree Atrioventricular Block
7%
Incidence Estimates
7%
Magnetic Resonance Imaging Study
15%
Major Adverse Cardiovascular Events
7%
Matched Cohort Study
7%
Myocardial Infarction
7%
Non-invasive Method
7%
Percutaneous Intervention
7%
Prognostic Value
100%
Regadenoson
100%
Risk Stratification
7%
Safety Analysis
7%
Safety Value
100%
Sinus Node Dysfunction
7%
Stress Cardiovascular Magnetic Resonance
100%
Stress CMR
30%
Transplantation
7%
Vasodilator Testing
7%
Medicine and Dentistry
Adverse Effect
15%
Cardiac Allograft Vasculopathy
7%
Cardiac Magnetic Resonance Imaging
100%
Cardiovascular Disease
7%
Cohort Analysis
7%
Cumulative Incidence
7%
Heart Graft
100%
Heart Transplantation
15%
Myocardial Infarction
7%
Non Invasive Procedure
7%
Percutaneous Intervention
7%
Regadenoson
100%
Retransplantation
7%
Second-Degree Atrioventricular Block
7%
Sinus Node Disease
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiac Allograft Vasculopathy
8%
Cardiovascular Disease
8%
Cohort Study
8%
Heart Infarction
8%
Regadenoson
100%
Second Degree Atrioventricular Block
8%
Sinus Node Disease
8%